TAZIP

THERAPEUTIC INDICATIONS

Tazip is indicated for the treatment of the following infections in adults and children patients older than 2 years.

Adult and adolescent patients

• severe pneumonia including hospital-acquired and ventilator-associated pneumonia;
• complicated urinary tract infections (including pyelonephritis);
• complicated intraabdominal infections;
• Complicated skin and soft tissue infections (including diabetic foot infections).

Treatment of patients with bacteraemia that occurs in connection with, or which are suspected to be associated with any of the above infections.

The product Tazip can be used in the treatment of neutropenic patients with fever, for which there is a suspicion that it is caused by bacterial infections.

Children aged 2 to 12 years

• complicated intra-abdominal infections

Tazip can be used in the treatment of neutropenic patients with fever, for which there is a suspicion that it is caused by bacterial infections.

It is necessary to ensure respect for official guidance on the appropriate use of antibacterial agents.

DISPENSING AND REIMBURSEMENT

Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.